Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition 0 10.11.2024 20:26 Forbes.com The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S. patient out-of-pocket costs are too high. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
